Advertisement

Index by author

June 01, 2024; Volume 52,Issue 6

  1. Ansaar, Radwan

    1. Activation of Cryptic Donor Splice Sites within the UDP-Glucuronosyltransferase (UGT)1A First-Exon Region Generates Variant Transcripts That Encode UGT1A Proteins with Truncated Aglycone-Binding Domains
      Dong Gui Hu, Shashikanth Marri, Julie-Ann Hulin, Radwan Ansaar, Peter I Mackenzie, Ross A McKinnon and Robyn Meech
      Drug Metabolism and Disposition June 2024, 52 (6) 526-538; DOI: https://doi.org/10.1124/dmd.123.001565

  2. Beers, Jessica L.

    1. Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity
      Jessica L. Beers, Zhu Zhou and Klarissa D. Jackson
      Drug Metabolism and Disposition June 2024, 52 (6) 508-515; DOI: https://doi.org/10.1124/dmd.123.001435

  3. Dasilva, Ethan

    1. Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes
      Lloyd Wei Tat Tang, Ethan DaSilva, Kimberly Lapham and R. Scott Obach
      Drug Metabolism and Disposition June 2024, 52 (6) 565-573; DOI: https://doi.org/10.1124/dmd.124.001693

  4. Ekins, Sean

    1. In Vitro Characterization and Rescue of VX Metabolism in Human Liver Microsomes
      In Vitro Characterization and Rescue of VX Metabolism in Human Liver Microsomes
      Thomas R. Lane, David Koebel, Eric Lucas, Robert Moyer and Sean Ekins
      Drug Metabolism and Disposition June 2024, 52 (6) 574-579; DOI: https://doi.org/10.1124/dmd.124.001695

  5. Fan, Wu

    1. Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
      Open Access
      Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
      Yi Zhang, Jingyu Feng, Yang Mi, Wu Fan, Runwen Qin, Yingwu Mei, Ge Jin, Jian Mao and Haifeng Zhang
      Drug Metabolism and Disposition June 2024, 52 (6) 555-564; DOI: https://doi.org/10.1124/dmd.124.001665

  6. Feng, Jingyu

    1. Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
      Open Access
      Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
      Yi Zhang, Jingyu Feng, Yang Mi, Wu Fan, Runwen Qin, Yingwu Mei, Ge Jin, Jian Mao and Haifeng Zhang
      Drug Metabolism and Disposition June 2024, 52 (6) 555-564; DOI: https://doi.org/10.1124/dmd.124.001665

  7. Geffert, Raeanne M.

    1. Kinase Inhibitors FDA Approved 2018–2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities
      Bethany D. Latham, Raeanne M. Geffert and Klarissa D. Jackson
      Drug Metabolism and Disposition June 2024, 52 (6) 479-492; DOI: https://doi.org/10.1124/dmd.123.001430

  8. Georgi, Katrin

    1. Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds
      Lena C. Preiss, Katrin Georgi, Volker M. Lauschke and Carl Petersson
      Drug Metabolism and Disposition June 2024, 52 (6) 539-547; DOI: https://doi.org/10.1124/dmd.123.001638

  9. Guengerich, F. Peter

    1. Cytochrome P450 Enzymes as Drug Targets in Human Disease
      F. Peter Guengerich
      Drug Metabolism and Disposition June 2024, 52 (6) 493-497; DOI: https://doi.org/10.1124/dmd.123.001431

  10. Hackett, John C.

    1. Open Access
      HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation
      Hannah M. Work, John C. Hackett and Jed N. Lampe
      Drug Metabolism and Disposition June 2024, 52 (6) 516-525; DOI: https://doi.org/10.1124/dmd.123.001434
« Previous (Pages : 1 2 3 4 5 ... 5) Next »
Back to top

In this issue

Advertisement